Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2020, Vol. 25 ›› Issue (4): 387-392.doi: 10.12092/j.issn.1009-2501.2020.04.006

Previous Articles     Next Articles

Forsythiaside B inhibits the proliferation activity of HeLa cells though transcription factor NF-κB

ZHANG Zhe1, LYU Yu2, HUANG Panhao2   

  1. 1Reproductive Center of Hunan Provincial People's Hospital/the First Affiliated Hospital of Hunan Normal University, Changsha 410005, Hunan, China; 2Department of Pharmacy, the Third XiangYa Hospital of Central South University, Changsha 410078, Hunan, China
  • Received:2019-12-30 Revised:2020-03-10 Online:2020-04-26 Published:2020-05-12

Abstract: AIM: To study the effects of forsythiaside B on HeLa cells proliferation by inhibiting NF-κB through p21/Cyclin E/CDK2 signaling pathway. METHODS: The cell activity of HeLa cells was observed by MTT assay after 24 h, 48 h and 72 h treatment with different concentration (1, 2, 4 μmol/L) of forsythiaside B. The clone formation of HeLa cells was evaluated with the condition of different concentrations of forsythiaside B. The expression of transcription factor NF-κB (p-p65 and p65) was determined, and the expression of p21, Cyclin E and CDK2 were detected as well.RESULTS:Forsythioside B inhibited the clone formation of HeLa cells in concentration dependent manner, and the inhibitory effect on HeLa cells' proliferation by forsythioside B was in both time and concentration dependent manner. Forsythioside B up-regulated p21 protein expression and down-regulated p-p65, Cyclin E and CDK2 protein expression. CONCLUSION:Forsythioside B inhibits the transcription factor NF-κB and affects the p21/Cyclin E/CDK2 signaling pathway, thus inhibiting the proliferation of HeLa cells.

Key words: forsythiaside B, NF-κB, HeLa cell, p21

CLC Number: